Ontology type: schema:ScholarlyArticle
2016-04
AUTHORSGeorge Dranitsaris, Sasha Mazzarello, Stephanie Smith, Lisa Vandermeer, Nathaniel Bouganim, Mark Clemons
ABSTRACTPURPOSE: The objective of this exploratory analysis was to determine if individual patient risk factors could be used to optimize chemotherapy-induced nausea and vomiting (CINV). METHODS: Through validated risk prediction models which quantify patient risk factors, 152 patients with early-stage breast cancer scheduled to received adjuvant anthracycline-based chemotherapy were categorized as being at low (level 0) or high-risk (level 1) for CINV. Prior to the first cycle of chemotherapy, low-risk patients received ondansetron and dexamethasone, while high-risk level 1 patients also received aprepitant. For subsequent cycles, patients who experienced CINV had their antiemetics changed in a stepwise manner to level 2 (extended-duration dexamethasone) or level 3 (extended-duration dexamethasone and low-dose olanzapine). RESULTS: The study enrolled 152 patients who received 484 cycles of chemotherapy. Forty patient cycles were classified as low risk (level 0) compared to 201, 162 and 81 that were classified as high-risk levels 1, 2 and 3, respectively. Complete control of acute and delayed vomiting was comparable and was achieved in over 85 % of patients across all risk levels (p = 0.56 and p = 0.99). In contrast, complete control of acute and delayed nausea was reduced in risk levels 1 to 3 compared to level 0 (acute = 51.2, 58.0, 45.7 vs. 70.0 %; p = 0.013)-(delayed = 32.8, 45.7, 34.6 vs. 62.5 %; p < 0.001). CONCLUSIONS: Despite the addition of aprepitant, extended-duration dexamethasone and olanzapine, patients at high risk for CINV due to personal risk factors failed to achieve good nausea control. More... »
PAGES1563-1569
http://scigraph.springernature.com/pub.10.1007/s00520-015-2944-x
DOIhttp://dx.doi.org/10.1007/s00520-015-2944-x
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1028609174
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/26381427
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Oncology and Carcinogenesis",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Adult",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Aged",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Antiemetics",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Antineoplastic Agents",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Breast Neoplasms",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Dexamethasone",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Female",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Middle Aged",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Morpholines",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Nausea",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Ondansetron",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Outcome Assessment (Health Care)",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Practice Guidelines as Topic",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Risk Factors",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Vomiting",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Ottawa Hospital",
"id": "https://www.grid.ac/institutes/grid.412687.e",
"name": [
"The Ottawa Hospital Cancer Centre, Ottawa, Canada",
"283 Danforth Ave, Suite 448, M4K 1N2, Toronto, Ontario, Canada"
],
"type": "Organization"
},
"familyName": "Dranitsaris",
"givenName": "George",
"id": "sg:person.01036510774.09",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036510774.09"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Ottawa Hospital",
"id": "https://www.grid.ac/institutes/grid.412687.e",
"name": [
"The Ottawa Hospital Cancer Centre, Ottawa, Canada"
],
"type": "Organization"
},
"familyName": "Mazzarello",
"givenName": "Sasha",
"id": "sg:person.0737376756.24",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0737376756.24"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Ottawa Hospital",
"id": "https://www.grid.ac/institutes/grid.412687.e",
"name": [
"The Ottawa Hospital Cancer Centre, Ottawa, Canada"
],
"type": "Organization"
},
"familyName": "Smith",
"givenName": "Stephanie",
"id": "sg:person.0651052101.37",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0651052101.37"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Ottawa Hospital",
"id": "https://www.grid.ac/institutes/grid.412687.e",
"name": [
"The Ottawa Hospital Cancer Centre, Ottawa, Canada"
],
"type": "Organization"
},
"familyName": "Vandermeer",
"givenName": "Lisa",
"id": "sg:person.0761055556.65",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0761055556.65"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Ottawa Hospital",
"id": "https://www.grid.ac/institutes/grid.412687.e",
"name": [
"The Ottawa Hospital Cancer Centre, Ottawa, Canada"
],
"type": "Organization"
},
"familyName": "Bouganim",
"givenName": "Nathaniel",
"id": "sg:person.01121740556.48",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01121740556.48"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Ottawa Hospital",
"id": "https://www.grid.ac/institutes/grid.412687.e",
"name": [
"The Ottawa Hospital Cancer Centre, Ottawa, Canada"
],
"type": "Organization"
},
"familyName": "Clemons",
"givenName": "Mark",
"id": "sg:person.01216107435.90",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01216107435.90"
],
"type": "Person"
}
],
"citation": [
{
"id": "https://doi.org/10.1093/annonc/mdl019",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1007120853"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.2010.31.7859",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1012116655"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.2010.34.4614",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1014939429"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/bf00365579",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1017912982",
"https://doi.org/10.1007/bf00365579"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s10147-015-0786-7",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1024417690",
"https://doi.org/10.1007/s10147-015-0786-7"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1093/annonc/mdu110",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1027015824"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1093/annonc/mds541",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1029598491"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.3747/co.19.1074",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1032134344"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00520-014-2138-y",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1032627889",
"https://doi.org/10.1007/s00520-014-2138-y"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/j.ejca.2010.10.013",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1034049872"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1093/annonc/mdp160",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1035398669"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/j.ejon.2004.03.006",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1035623421"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00520-012-1710-6",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1038084962",
"https://doi.org/10.1007/s00520-012-1710-6"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00520-003-0482-4",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1038839491",
"https://doi.org/10.1007/s00520-003-0482-4"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.2006.06.4451",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1042630049"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1001/jamaoncol.2015.3730",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1048305164"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/j.suponc.2012.05.001",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1054750673"
],
"type": "CreativeWork"
},
{
"id": "https://app.dimensions.ai/details/publication/pub.1077181555",
"type": "CreativeWork"
}
],
"datePublished": "2016-04",
"datePublishedReg": "2016-04-01",
"description": "PURPOSE: The objective of this exploratory analysis was to determine if individual patient risk factors could be used to optimize chemotherapy-induced nausea and vomiting (CINV).\nMETHODS: Through validated risk prediction models which quantify patient risk factors, 152 patients with early-stage breast cancer scheduled to received adjuvant anthracycline-based chemotherapy were categorized as being at low (level 0) or high-risk (level 1) for CINV. Prior to the first cycle of chemotherapy, low-risk patients received ondansetron and dexamethasone, while high-risk level 1 patients also received aprepitant. For subsequent cycles, patients who experienced CINV had their antiemetics changed in a stepwise manner to level 2 (extended-duration dexamethasone) or level 3 (extended-duration dexamethasone and low-dose olanzapine).\nRESULTS: The study enrolled 152 patients who received 484 cycles of chemotherapy. Forty patient cycles were classified as low risk (level 0) compared to 201, 162 and 81 that were classified as high-risk levels 1, 2 and 3, respectively. Complete control of acute and delayed vomiting was comparable and was achieved in over 85 % of patients across all risk levels (p = 0.56 and p = 0.99). In contrast, complete control of acute and delayed nausea was reduced in risk levels 1 to 3 compared to level 0 (acute = 51.2, 58.0, 45.7 vs. 70.0 %; p = 0.013)-(delayed = 32.8, 45.7, 34.6 vs. 62.5 %; p < 0.001).\nCONCLUSIONS: Despite the addition of aprepitant, extended-duration dexamethasone and olanzapine, patients at high risk for CINV due to personal risk factors failed to achieve good nausea control.",
"genre": "research_article",
"id": "sg:pub.10.1007/s00520-015-2944-x",
"inLanguage": [
"en"
],
"isAccessibleForFree": false,
"isPartOf": [
{
"id": "sg:journal.1103473",
"issn": [
"0941-4355",
"1433-7339"
],
"name": "Supportive Care in Cancer",
"type": "Periodical"
},
{
"issueNumber": "4",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "24"
}
],
"name": "Measuring the impact of guideline-based antiemetic therapy on nausea and vomiting control in breast cancer patients with multiple risk factors",
"pagination": "1563-1569",
"productId": [
{
"name": "readcube_id",
"type": "PropertyValue",
"value": [
"8849158ede53a9841b9474d00a520ef059919f0e1496932ccddcf16878717d09"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"26381427"
]
},
{
"name": "nlm_unique_id",
"type": "PropertyValue",
"value": [
"9302957"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1007/s00520-015-2944-x"
]
},
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1028609174"
]
}
],
"sameAs": [
"https://doi.org/10.1007/s00520-015-2944-x",
"https://app.dimensions.ai/details/publication/pub.1028609174"
],
"sdDataset": "articles",
"sdDatePublished": "2019-04-11T00:16",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8695_00000513.jsonl",
"type": "ScholarlyArticle",
"url": "http://link.springer.com/10.1007%2Fs00520-015-2944-x"
}
]
Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00520-015-2944-x'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00520-015-2944-x'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00520-015-2944-x'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00520-015-2944-x'
This table displays all metadata directly associated to this object as RDF triples.
227 TRIPLES
21 PREDICATES
63 URIs
37 LITERALS
25 BLANK NODES